chemical structure semaglutide molecule Glp-1 Agonist Drug Stock Vector (Royalty Free) 2352989741 α-Glu(side chain)-Semaglutide - Daicel Pharma

Trial registration Clinicaltrials.gov, NCT04777396 and NCT04777409

Inspiring Transformations: Before and After Results Big changes in life often start with small steps

Rates of patients switching from AOM tirzepatide declined in the months following July 2025 and returned to near baseline levels by October, and growth in AOM tirzepatide prescribing rebounded after the initial decline

Downsides include potential gastrointestinal side effects, nausea, diarrhea, gas, and constipation

In practice, the largest risks cluster in people losing weight quickly, especially with older age, a prior gallstone history, or higher triglycerides